Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

NCT01516580 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

482

Enrollment

OTHER

Sponsor class

Conditions

B-cell Non Hodgkin Lymphoma
Mature B-cell Leukemia Burkitt-type

Interventions

DRUG: Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C
DRUG: Rituximab, Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]